Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CLINICAL PRACTICE GUIDELINE IMPACT ON PHYSICIAN BEHAVIOR

Executive Summary

CLINICAL PRACTICE GUIDELINE IMPACT ON PHYSICIAN BEHAVIOR is still unproven, Agency for Health Care Policy & Research Administrator-designate Clifton Gaus maintained at a National Health Lawyers Association meeting April 7. The idea that guidelines have an impact on clinical practice "is well accepted... by both professional communities and the large [payer] organizations," Gaus said. However, he added, "we're a far ways away...from proving to the world that the use of those guidelines in fact changes dramatically the behavior of physicians."

Latest Headlines
See All
UsernamePublicRestriction

Register

PS024296

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel